Central Garden & Pet Company CENTA

34.06 (0.13) (0.38%) as of 25 Sep
Market cap
$2.2B
P/E
12.6×

Insider Decisions

in millions of $
Nov 25 Feb 26 May 26 Aug 26
Buy — — — — — — — — — — — —
Sell — — — — — — — — — — — —
Insider Ownership 19.32%

Capital & Financial Ratios

Market Cap 2,200.00
Revenue 3,084.06
Net Income 166.39
Free Cash Flow 345.63
Net Debt 180.84
Current Ratio 3.79
Debt/Equity 0.68
P/E ratio 12.61
P/S ratio 0.68
P/B ratio 1.20
Past 5Y EPS Growth 0.06%
This Y EPS Growth 8.94%
Next Y EPS Growth 4.98%
Next 5Y EPS Growth 6.75%
in millions of $

Dividends

Payout Ratio 0.00
Annual Dividend Rate —
Annual Dividend Yield 10.80%

Assets vs Liabilities

2023 2024 2025 Q'26
Cash 503 768 898 1,012
Receivables 333 326 325 460
Inventory 838 758 722 632
Other — — — —
1,707 1,887 1,976 2,135
2023 2024 2025 Q'26
Payables 191 213 235 217
ST’ Debt 0 0 0 0
Other — — — —
458 515 539 564
in millions of $

Compound Annual Growth

10y 5y 3y
Sales 6.60% 3.03% (2.14%)
Cash Flow 14.29% 4.70% 0.00%
Earnings 17.68% 6.18% 2.29%
Book Value 12.09% 8.02% 5.89%

Revenue

Dec Mar Jun Sep Year
’26 617 906 882 — —
’25 656 834 961 678 3,129
’24 635 900 996 669 3,200
’23 628 909 1,023 750 3,310
’22 661 954 1,015 707 3,339
’21 592 935 1,037 739 3,304
’20 483 703 833 676 2,696
in millions of $ · fiscal quarters ending in the months shown

Operating Cash Flow

Dec Mar Jun Sep Year
’26 (70) (50) 327 — —
’25 (69) (47) 265 183 333
’24 (70) (25) 286 203 395
’23 (63) (34) 325 154 382
’22 (92) (180) 190 48 (34)
’21 (36) (84) 299 72 251
’20 (18) (75) 182 175 264
in millions of $ · fiscal quarters ending in the months shown

Free Cash Flow

Dec Mar Jun Sep Year
’26 (81) (60) 315 — —
’25 (75) (58) 252 172 291
’24 (80) (34) 272 193 352
’23 (81) (46) 314 141 328
’22 (117) (231) 167 32 (149)
’21 (51) (103) 275 49 171
’20 (28) (84) 174 159 221
in millions of $ · fiscal quarters ending in the months shown

EPS

Dec Mar Jun Sep Year
’26 0.11 1.28 1.45 — —
’25 0.21 0.98 1.52 (0.16) 2.55
’24 0.01 0.93 1.19 (0.51) 1.62
’23 (0.13) 0.72 1.25 0.04 1.88
’22 0.13 1.02 1.11 (0.03) 2.24
’21 0.08 1.06 1.10 (0.05) 2.20
’20 (0.06) 0.62 1.02 0.20 1.76
fiscal quarters ending in the months shown

Target Price Range

Analyst price targets

Recommendation Rating

1.8
1Buy 2 3Hold 4 5Sell
2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028
8.80 22.50 21.71 16.41 17.33 28.28 26.95 27.02 27.70 25.97

Analyst estimates 2026–2028

Powerpack
Low Price
25.73 33.07 33.58 29.54 32.88 44.66 38.90 36.74 41.03 37.35
High Price
3,600 4,100 5,400 5,800 6,300 7,000 7,000 6,700 6,450 6,000
Employees
1 1 0 0 0 0 0 0 0 1
Revenue/Emp
1,829 2,054 2,215 2,383 2,696 3,304 3,339 3,310 3,200 3,129
Revenue
30.24% 30.80% 30.49% 29.54% 29.55% 29.39% 29.72% 28.60% 29.49% 31.87%
Gross Margin
70 126 127 119 154 195 199 162 142 217
EBT
3.81% 6.15% 5.75% 5.00% 5.70% 5.90% 5.96% 4.91% 4.45% 6.93%
EBT Margin
46 80 124 93 122 153 153 126 109 164
Net Income
42 44 49 53 57 77 84 90 106 89
Depreciation
29.88 32.72 34.27 33.58 39.93 49.02 50.19 50.54 48.71 49.59
Revenue/Sh
0.73 1.26 1.91 1.30 1.78 2.25 2.29 1.92 1.64 2.58
Earnings/Sh
2.47 1.82 1.77 2.89 3.91 3.72 (0.51) 5.83 6.01 5.27
Cash Flow/Sh
(0.39) (0.58) (0.59) (0.44) (0.64) (1.19) (1.73) (0.82) (0.66) (0.66)
Capex/Sh
2.09 1.25 1.18 2.44 3.28 2.53 (2.24) 5.00 5.35 4.61
Free CF/Sh
9.06 10.15 14.74 14.04 15.96 18.16 20.06 22.18 23.70 25.12
Book Value/Sh
61 63 65 71 68 67 67 65 66 63
Shares
27.25 24.02 13.65 17.11 16.06 15.36 11.99 16.58 19.17 11.45
PE Ratio
0.66 0.92 0.77 0.66 0.72 0.70 0.54 0.63 0.64 0.60
PS Ratio
2.19 2.95 1.79 1.58 1.81 1.89 1.36 1.43 1.32 1.18
PB Ratio
0.82 1.09 0.86 0.74 0.73 0.93 0.84 0.83 0.78 0.69
EV/Sales
11.79 28.56 25.01 10.13 8.95 17.97 (18.85) 8.43 7.06 7.41
EV/FCF
151 114 114 205 264 251 (34) 382 395 333
Op' Cash Flow
(24) (36) (38) (32) (43) (80) (115) (54) (43) (41)
Capex
128 78 76 173 221 171 (149) 328 352 291
FCF
481 463 1,004 1,029 1,085 1,021 1,088 1,249 1,371 1,437
Working Cap'
395 396 692 693 694 1,186 1,187 1,188 1,190 1,192
Total Debt
291 351 199 182 28 746 994 685 422 293
Net Debt
555 637 953 996 1,078 1,224 1,335 1,453 1,558 1,585
Sh' Equity
3.85% 6.34% 7.69% 4.72% 5.53% 5.56% 4.76% 3.77% 3.12% 4.54%
ROA
9.56% 9.88% 9.08% 8.06% 11.19% 8.08% 6.98% 6.16% 5.85% 8.32%
ROIC
8.39% 13.23% 15.55% 9.52% 11.64% 13.19% 11.89% 9.01% 7.17% 10.36%
ROE
predictions in italic, sparklines do not include predictions

All 10 years →

Fiscal years to Sep 2025 · latest quarter Jun 2026

Central Garden & Pet Company peers in Packaged Foods

All 71 Packaged Foods stocks →

Central Garden & Pet Company (CENTA) key facts

  • Central Garden & Pet Company (CENTA) is a Packaged Foods company in the Consumer Defensive sector, listed on Nasdaq.
  • Central Garden & Pet Company’s revenue for fiscal 2025 (year ended September 2025) was $3.1 billion, down 2.23% from fiscal 2024.
  • Net income was $164.0 million, or $2.58 per share (basic), a net margin of 5.20%.
  • As of September 25, 2026, CENTA traded at $34.06, a market capitalization of $2.2 billion.
  • At that price the stock trades at 12.6× trailing-twelve-month earnings and 0.7× sales.
  • Return on equity was 10.4% and debt-to-equity 0.68.

Source: company filings (standardised) and stockrow calculations.

Central Garden & Pet Company (CENTA) Latest News

News by impact score

Fine-tune

23 Sep

3

Nylabone, a brand in Central Garden & Pet (CENT/CENTA), launches its first chew toys made with real meats—chicken, bison, venison, bacon, and beef—to satisfy dogs' natural chewing instincts. Actress Ashley Tisdale partners with Nylabone to promote the line, including softer puppy variants for teething. The real-meat chews come in Original Bone, Textured Ring, Femur Bone, and Comfort-Hold Wishbone. Puppy variants include the Puppy Chew Groove Bone and a Groove Bone & Femur Bone twin pack in beef and bacon. Available now on Amazon, Chewy, and Walmart for puppies. Nylabone says chewing supports mood, reduces destructive behavior, mental engagement, and dental health. Part of Central Garden & Pet, which posted $3.1 billion in net sales in 2025. The release includes quotes from Ashley Tisdale and Miguel Zorrilla, SVP of Marketing. Introduces a differentiated real-meat chew line in a core pet category, likely modestly lifting sales while not fundamentally changing CENTA's overall trajectory.

21 Sep

3

Central Garden & Pet announced a planned leadership transition in its Garden segment. J.D. Walker, President of Garden Consumer Products, will retire effective September 26, 2026. Jason Barnes, Executive Vice President of Garden Consumer Products, will assume responsibility for sales, marketing and service across Central's Garden segment and manage Branded Controls, Grass Seed, Live Plants, Packet Seeds and Vendor Partner businesses. Walker will continue in a consulting role afterward. Barnes, who has led Garden Consumer Products since October 2025, brings more than two decades in the lawn and garden industry and previously led Bell Nursery, DoMyOwn, and Central’s Vendor Partner business. CEO Niko Lahanas calls Barnes a strong fit to accelerate growth and innovation; Walker helped expand the portfolio through acquisitions including Arden®, Bell Nursery, Hopewell Nursery, Green Garden™ Products and DoMyOwn™. Central is NASDAQ: CENT/CENTA, with fiscal 2025 net sales of $3.1 billion, based in Walnut Creek, CA, and about 6,000 employees. Internal succession in a key segment could affect execution and growth trajectory while maintaining continuity.

4 Sep

3

Central Garden & Pet raises its profit outlook while valuation debate sharpens around the company. Profit outlook increase signals better financial expectations with valuation concerns creating moderate counterbalance.

3 Sep

3

Central Garden & Pet raised full-year guidance despite a sales decline. Guidance increase points to stronger expected results that may offset reported sales weakness and influence near-term valuation.

26 Aug

3

Central Garden & Pet (NASDAQ:CENT) Q2 earnings are compared against peer household products stocks. Q2 earnings data can moderately affect short-term financial views and market positioning.

12 Aug

4

Central Garden & Pet eyes record profits and European expansion via TRIXIE deal. TRIXIE deal enables record profits and European market entry for Central Garden & Pet.

9 Aug

4

Central Garden & Pet acquires majority interest in a deal and signals plans for additional acquisitions. Majority interest deal plus signaled further acquisitions represent major strategic moves that could significantly alter company trajectory.

6 Aug

4

Central Garden & Pet beat Q3 earnings expectations and raised its FY26 EPS outlook. Q3 earnings beat and raised FY26 EPS guidance indicate stronger financial performance and improved future prospects.

3 transcript

Central Garden & Pet Co reports Q3 2026 earnings call results focused on organic growth. Routine earnings highlights on organic growth point to moderate short-term market effects without major strategic shifts.

5 Aug

3

Central Garden & Pet Q3 earnings call covered revenue, segment performance, and forward outlook for pet and garden businesses. Quarterly results update investor views on near-term financials without altering long-term strategy.

3

Central Garden & Pet Company beat analyst estimates for Q3 earnings and revenue. Beating quarterly earnings and revenue estimates can lift short-term stock performance and investor sentiment.

3

Central Garden & Pet (NASDAQ:CENT) exceeded Q2 CY2026 expectations. Quarterly earnings outperformance typically lifts near-term stock price and sentiment without altering long-term strategy.

3

Central Garden & Pet Company announced its Q3 fiscal 2026 financial results. Quarterly results release can shift investor assessment of financial performance.

29 Jul

3

Q3 earnings for Central Garden & Pet Company (CENTA) are projected to decline. Expected Q3 earnings decline may pressure stock performance and investor sentiment.

3

Trixie pet treats in Germany sells majority stake to Central Garden & Pet. Majority stake purchase in Trixie expands Central Garden & Pet operations into German pet treats market.

28 Jul

4

Central Garden & Pet acquires TRIXIE to expand its European pet business. TRIXIE acquisition delivers major strategic expansion of European pet operations and market reach.

27 Jul

4

Central Garden & Pet strikes TRIXIE deal to target European pet-supplies leadership. TRIXIE acquisition drives major European expansion for Central Garden & Pet.

4

Central Garden & Pet Company will acquire a majority interest in TRIXIE Heimtierbedarf GmbH & Co. KG, Europe’s leading pet supplies and pet snacks company. Acquisition of Europe’s top pet supplies firm expands Central Garden & Pet market presence and revenue base substantially.

13 Jul

3

Central Garden & Pet's Cost & Simplicity Program shows potential to further expand margins through continued cost management and operational streamlining. Cost & Simplicity Program targets ongoing margin expansion at Central Garden & Pet.

6 Jul

3

Central Garden & Pet Company examines whether pet product innovations can drive its next growth phase. Pet innovations may moderately influence financial performance and competitive positioning.

26 Jun

3

Central Garden & Pet (CENT) releases Q1 earnings, prompting buy, sell, or hold analysis for the stock. Q1 earnings results may moderately sway near-term investor sentiment and stock price without altering core operations.

16 May

3

Central Garden & Pet held its Q1 earnings call covering financial results and addressing the top five analyst questions on performance, margins, and outlook. Q1 earnings call details provide moderate insight into near-term results and strategy without indicating major shifts.

12 May

4

Wall Street analysts expect Central Garden & Pet Company (CENTA) stock to rally 35.89%, signaling strong growth potential. Analyst consensus targets 35.89% upside for CENTA, likely shifting investor sentiment and stock trajectory.

7 May

4

Central Garden & Pet (CENTA) Q2 earnings beat estimates, fueled by strong sales in pet and garden segments. Q2 earnings beat on robust core pet and garden sales indicates strong financial momentum with significant positive impact on market performance.

6 May

4 transcript

Central Garden & Pet Company (CENTA) released its Q2 2026 earnings call transcript detailing quarterly financial results, management commentary, and future outlook. Q2 2026 earnings transcript reveals financial performance and guidance directly influencing CENTA's stock price and investor expectations.

4

Central Garden & Pet Company released Q2 earnings call highlights, covering financial results, garden and pet segment performance, strategic updates, and forward guidance. Q2 earnings highlights detail financial performance and outlook, significantly influencing investor sentiment and stock trajectory.

4

Central Garden & Pet Company (CENTA) surpassed Q2 earnings and revenue estimates. Beating Q2 earnings and revenue estimates boosts investor sentiment and signals strong financial momentum for future performance.

4

Central Garden & Pet (NASDAQ:CENT) beat Q1 CY2026 sales expectations. Beating quarterly sales expectations drives positive investor sentiment and enhances short-to-medium term market performance.

4

Central Garden & Pet Company announced record financial results for Q2 fiscal 2026. Record Q2 results demonstrate strong financial performance poised to significantly boost investor sentiment and market valuation.

3

Central Garden & Pet Company released Q2 2026 earnings call summary, detailing financial results, segment performance, outlook, and strategic updates. Q2 earnings summary highlights financial performance and guidance, moderately influencing stock sentiment and trajectory.

stockrow.com/CENTA · Data as of Jun 30, 2026 · For information only; not investment advice. · © 2026 stockrow.com